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Purpose: To determine the incidence of particulate mbolization after carotid endarterec- 
tomy (CEA), the effect of dextran-40 infusion in patients with sustained postoperative 
embolization, and the impact of transcranial Doppler (TCD) monitoring plus adjuvant 
dextran therapy on the rate of postoperative carotid thrombosis. 
Methods: Prospective study in 100 patients who underwent CEA with 6-hour postopera- 
tive monitoring using a TCD that was modified to allow automatic, intermittent record- 
ing from the ipsilateral middle cerebral artery waveform (10 minute sample every 30 
minutes). An incremental dextran-40 infusion was commenced if 25 or more emboli were 
detected in any 10-minute period. 
Results: Overall, 48% of patients had one or more emboli detected in the postoperative 
period, particularly in the first 2 hours. However, sustained embolization that required 
Dextran therapy developed in only five patients. In each case, the rate of embolization 
rapidly diminished. 
Conclusions: A small proportion of patients have sustained embolization after CEA, 
which in previous tudies has been shown to be highly predictive of thrombotic stroke. 
Intervention with dextran reduced and subsequently stopped all the emboli n those in 
whom it was used and contributed to a 0% perioperative morbidity and mortality rate in 
this series. (J Vasc Surg 1997;26:579-84.) 
In the International Trials, the risk of having an 
ipsilateral stroke after carotid endarterectomy (CEA) 
was 5% to 7%. 1,2 Despite this result, CEA was still 
able to confer a 45% relative reduction in the long- 
term risk of stroke in symptomatic patients with a 
severe (>70%) stenosis as compared with best medi- 
cal therapy alone. If, however, the operative risk 
could be reduced to zero, CEA could effect an overall 
75% relative risk reduction in ipsitateral stroke long: 
term. 
There are two main types of operation-related 
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stroke. The intraoperative stroke (IOS) is apparent 
on recovery from anesthesia nd is directly attribut- 
able to intraoperative ischaemia or embolization. 
The postoperative stroke occurs sometime-after an 
otherwise uneventful recovery from anesthesia. 
In an earlier report, we showed that a policy of 
quality control assessment (transcranial Doppler 
[TCD ] monitoring plus completion angioscopy) was 
associated with a reduction in our rate of IOS from 
4% to 0%. a However, although we have now per- 
formed 360 CEAs since we last had a patient have an 
intraoperative stroke, 4 our quality control program 
has not altered our rate of postoperative internal 
carotid artery (ICA) thrombotic stroke, which re- 
mained at 3% between )'anuary 1992 and August 
1995. 
Previous work from our group, however, sug- 
gested that postoperative ICA thrombosis was pre- 
ceded by a phase of asymptomatic microparticulate 
embolization, which could be detected by TCD ul- 
trasound, s It was predicted and subsequently dem- 
onstrated that a TCD diagnosis of embolization 
could be used to permit early therapeutic or surgical 
intervention to prevent ICA thrombosis. 6 This work 
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has subsequently been corroborated by Levi et al., 7 
who have shown that 60% of patients who have 
greater than 50 embolic signals detected per hour in 
the early postoperative period will go on to have a 
stroke. 
In September 1995 we implemente d a prospec- 
tive study in which patients who were undergoing 
CEA were monitored after operation for 6 hours 
using TCD. Patients with sustained embolization 
were treated with incremental dose infusions of dex- 
tran 40. The aims were first, to determine the overall 
incidence of postoperative embolization; second, to 
see whether the rate of embolization was altered by 
administration of the antiplatelet agent dextran-40; 
and third, to see whether such a policy altered our 
overall postoperative ICA thrombotic stroke rate. 
MATERIALS AND METHODS 
Indus ion and exclusion criteria. Between Sep. 
12, 1995, and Aug. 13, 1996, 133 patients under- 
went CEA in this unit for the correction of a severe 
(>70%) stenosis of the ICA. Of  these, 100 were 
serially monitored for 6 hours after the operation 
using a modified TCD system that was specially de- 
signed for this project. The remaining 33 patients 
were not included in this study because of  an inacces- 
sible cranial window for TCD (n = 12), refusal to 
give informed consent (n = 1), or because two CEAs 
were performed simultaneously in two patients and 
only one modified TCD was available for postopera- 
tive monitoring (n = 20). Ethical permission for this 
study was given by the Leicestershire Ethics Com- 
mittee. 
The median age of the study group was 70 years 
(range, 44 to 84 years). Thirty-five were female and 
65 male. Sixty-four had had a transient ischemic 
attack or amaurosis fugax, 31 had had an established 
stroke, and only five were clinically asymptomatic 
before surgery. Treated hypertension was a risk fac- 
tor in 61%, 36% had a history of ischemic heart 
disease, and 8% were diabetic. An ipsilateral >70% 
stenosis was present in 99% of patients (70% to 79%, 
n = 27; 80% to 89%, n = 33; 90% to 99%, n = 39). 
The remaining patient had a 65% symptomatic ste- 
nosis with a contralateral occlusion. Overall, 18% of 
the study group had a contralateral occlusion or 
stenosis >70%. 
CEA. Aspirin therapy was not stopped before 
surgery. CEA was performed with the patient under 
normocarbic, normotensive general anesthesia using 
systemic (5000 IU) heparinization. The endarterec- 
tomy was performed via a longitudinal arteriotomy in
the same standardized manner by one of three con- 
sultants in vascular surgery (PRFB, ARN, NIML) or 
by a higher surgical trainee under consultant supervi- 
sion. A shunt (Pruitt-Inahara) was used in all but two 
patients, the proximal and distal intimal steps were 
routinely tacked down with 7-0 prolene (Ethicon), 
and all arteriotomies were closed with a collagen- 
impregnated Dacron patch (Intervascular). 
Continuous intraoperative TCD monitoring of 
blood flow velocity in the ipsilateral middle cerebral 
artery (MCA) was performed using a 2 MHz pulsed 
wave probe (via the transtemporal window), secured 
with an elastic headband and connected to a Scimed 
PC842 TCD system (Scimed, Bristol, U.K.). During 
the operation, one of the research fellows experi- 
enced in TCD (JS, NL) was available to supervise 
minor revisions to the probe position and to inform 
the surgeon of unexpected phenomena. The surgeon 
was thereafter permitted to take whatever action he 
thought most appropriate to ensure the optimal out- 
come. For example, embolization during the carotid 
dissection phase warned of unstable plaques and per- 
mitted early ICA clamping, 8 whereas hunt malfunc- 
tion (kinking, sustained embolization, low flow) was 
immediately identified and steps taken to correct it 
(exclusion of kinking, deflation of distal Pruitt shunt 
balloon, or augmentation of blood pressure to im- 
prove shunt flow). In general, we aimed to keep 
MCA velocity at 15 cm/sec or greater throughout 
the procedure, preferably 20 cm/sec or greater. 
After endarterectomy and before complete clo- 
sure of the patch, the shunt was removed and the 
carotid vessels were flushed and irrigated with hepa- 
rinized saline solution and then reclamped. The lu- 
men was then inspected with an angioscope to cor- 
rect any residual technical error. The policy of the 
unit was to remove any fragments of thrombus and 
repair any intimal flap greater than 3 mm. 4 Where 
necessary, an estimate of luminal sizing of any abnor- 
mality was based on comparison with the 2 mm 
diameter head of the forceps that can be passed own 
the instrument channel of  the hysteroscope. 
Postoperative care. Patients recovered from an- 
esthesia in the operating theatre and were then trans- 
ferred through to the High Dependency Unit or the 
recovery area of theatre for a further 6 hours. No 
patient in this series was found to have any new 
neurologic deficit on recovery from anesthesia. 
The TCD probe was repositioncd to monitor 
blood flow in the MCA on the operated side. In 
theory, unregulated continued exposure to ultra- 
sound could be potentially harmful, causing cranial 
tissue heating and headache. To reduce the theoret- 
ical risk of continuous exposure to ultrasound, we 
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Table I. Incidence of postoperative 
embolization i 100 patients 
No. of emboli No. of patients % 
0 52 52 
1 to 10 23 23 
11 to 25 10 23 
26 to 50 7 7 
51 to 75 2 2 
76 to 100 1 1 
>100 5 5 
3O 
number of 
pat ients  
20 
10 
developed our own integrated TCD system that au- 
tomatically switched itself on for a 10-minute period 
every 30 minutes. The system was programmed to
automatically boot up at the same preset focussing 
depth, gain setting, and power rating on each occa- 
sion. All waveform data were recorded onto digital 
audio tape for off-line analysis ofembolic signals. In a 
previous study, we have shown that any embolic 
signals detected in the early postoperative p riod are 
exclusively particulate. 9 Accordingly, for the pur- 
poses of this study any emboli detected uring the 
6-hour period of study were assumed to be nongas- 
eous. Postoperative monitoring continued for 6 hours, 
during which any loss of signal was corrected by 
adjustments to the probe position by research fellows 
experienced in TCD (JS, NL, JD). 
Ifa patient was found to have 25 or more emboli 
detected during any 10-minute period, he or she was 
commenced on an incremental intravenous infusion 
of dextran-40, initially 20 ml/hr. The threshold of 
25 emboli was derived from previous work in the 
department. 3,5,6 If the rate of embolization did not 
diminish, the infusion rate was gradually increased by 
5 ml/hr every 10 minutes up to a maximum of 40 ml 
per hour. Patients were not routinely tested for dex- 
tran hypersensitivity in this study. Once the dextran 
infusion rate was stabilized, it was then continued at 
that dose for a further 12 hours. If, however, embo- 
lization persisted espite incremental dextran ther- 
apy, the protocol required the carotid bifurcation to 
be examined by duplex (if possible) or the patient 
was considered for reexploration. Any new postoper- 
ative neurologic deficit was documented, and the 
patient was assessed by a neurologist. 
RESULTS 
Number of emboli. Table I summarizes the 
number of patients in whom emboli were detected 
during the 6-hour period of monitoring. Fifty-two 
patients had no emboli detected at any time, whereas 
48% had one or more emboli detected. Overall, 23% 
Fig. 
1 2 3 4 5 
hours post-op 
I. Onset ofembolization after CEA. 
had fewer than 10 emboli, 17% had between 11 and 
50, 3% had between 51 and 100, and only 5% of 
patients had more than 100 emboli detected uring 
the 6-hour period of monitoring. 
Timing of emboli. Fig. 1 shows that the onset 
of embolization occurred primarily within the first 
two postoperative hours. Nineteen patients began 
having embolization within the first postoperative 
hour, whereas afurther 24 began to have emboliza- 
tion during the second hour. Thereafter, the chances 
of any patient beginning to have embolization were 
very small. Of most practical importance was the 
observation that if embolization had not begun by 
the cnd of the third postoperative hour, it did not 
begin to do so thereafter. 
However, 10% of patients in whom embolization 
had begun in thc first three postoperative hours had 
more than 10 emboli detected uring the fourth to 
sixth postoperative hours, including one patient who 
had sustained embolization that required dextran 
therapy. 
Intervention with dextran-40. Five patients 
had more than 25 emboli detected uring any one 
10-minute period of monitoring and were thus com- 
menced on an incremental infusion of dextran-40. 
Table II details the numbers of emboli detected 
during each time period in these patients (each hour 
includes 20 minutes of actual monitoring). Dextran 
was started in the second postoperative hour in three 
patients, in the fourth postoperative hour in one 
patient, and in the sixth postoperative hour in the 
remaining patient. Fig. 2 illustrates the effect of the 
dextran infusion on the ensuing embolus count rate. 
Note that in the hour before starting the dextran, the 
embolus count was zero in three patients, thirteen in 
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Table II. Effect of dextran-40 on embolus count 
No. of emboli detected during each time period 
First hour Second hour Third hour Fourth hour Fifth hour Sixth hour Total 
Patient 1 0 
Patient 2 8 
Patient 3 0 
Patient 4 0 
Patient 5 0 
15 0 1 6 101" I23 
21 13 69* 14 108 233 
71" 63 4 2 1 141 
238* 16 27 14 12 297 
317" 63 44 35 17 476 
*Time period when dextran infusion was started. 
a fourth, and six in the fifth. Thercafter, the embolus 
count increased ramatically (Table II, Fig. 2). How- 
ever, after institution ofdextran therapy there was an 
immediate decline in the rate ofembolization. In one 
patient (Fig. 2) an initial fall was followed by a 
secondary rise in the rate of embolization, ecessitat- 
ing an increase in the infusion rate to 40 ml/hr.  
Thereafter, the rate of embolization rapidly fell to 
zero. In this series, none of the patients who received 
dextran-40 had any problems relating to bleeding, 
cardiac failure, or renal failure. 
Neurologic complications. None of the 100 
patients recovered from anesthesia with a new neuro- 
logic deficit, and none had any postoperative neuro- 
logic morbidity, giving an overall perioperative neu- 
rologic complication rate of 0%. 
DISCUSSION 
This study is the latest in a sequence whose un- 
derlying theme has been the prevention of  avoidable 
stroke during CEA. For the purposes of classifica- 
tion, timing, and audit within our unit, we have 
deliberately divided perioperative complications into 
those that occurred uring the operation (i.e., recov- 
ering from anesthesia with a new neurologic deficit) 
and after the operation (where a finite time period 
exists after ecovery from anesthesia and the develop- 
ment of any deficit). 
Our initial research corroborated the findings of 
others that certain patients appear to be more suscep- 
tible than others to intraoperative stroke and include 
those with a history of stroke, a residual neurologic 
deficit, computed tomographic scan evidence of pre- 
existing infarction, impaired cerebral vascular re- 
serve, and crescendo transient ischemic attacks, l°-12 
This, in conjunction with increased awareness that 
many operative strokes are attributable to inadver- 
tent technical error, 13 led us to draw the conclusion 
that high-risk patients were probably more suscepti- 
ble to relative hypoperfusion or microembolization 
than other individuals o that the margin for techni- 
cal error was reduced or possibly nonexistent) 4 
In our second project, we evaluated the role of 
several quality control assessment techniques and 
concluded that, for us at least, the combination of 
TCD monitoring plus completion angioscopy yielded 
the maximum in terms of identifying avoidable tech- 
nical error. 3 During this pilot study our IOS rate fell 
from 4% to 1%, 3 and after prospective implementa- 
tion of this quality control policy we have now per- 
formed more than 360 CEAs without any patient 
having an IOS. 4 
However, we were disappointed to observe that 
our quality control program had not altered our 
postoperative rate of thrombotic stroke. Between 
January 1992 and August 1995, nine of 300 patients 
(3%) had a stroke as a result of documented occlu- 
sion of either the cervical ICA (n = 7), the cervical 
external carotid artery (n = 1), or the ICA syphon 
(n = 1). All underwent either eexploration ( = 8) 
or autopsy (n = 1). Eight of the nine became symp- 
tomatic within 6 postoperative hours. 
In terms of underlying cause, thrombosis fol- 
lowed false aneurysm formation caused by excessive 
endarterectomy in one patient, whereas in a second 
patient occlusion of the carotid syphon at the site of a 
severe stenosis precipitated total ICA occlusion. A 
third patient had occlusion of her external carotid 
artery and had a tongue of embolizing thrombus 
protruding into the ICA at reexploration. In each of 
the six remaining patients, there was a large platelet- 
rich thrombus found within the endarterectomy 
zone, which otherwise showed no evidence of any 
technical error. In no patient was the thrombus pri- 
marily adherent o the patch angioplasty. Overall, 
four of the nine patients either died (n = 2) or had a 
major disabling stroke (n = 2), whereas four had a 
less severe stroke but with a residual deficit. Only one 
patient (external carotid artery occlusion with ICA 
embolization) made a complete recovery within 7 
days of onset. 
Postoperative thrombotic stroke is thus an unpre- 
dictable and devastating complication, and there 
does not seem to be any consistent method of iden- 
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tifying those at risk ofplatelet rich thrombus forming 
within the endarterectomy zone in the absence of 
technical error. Evidence suggests that platelets ad- 
here to the exposed collagen of the endarterectomy 
site within minutes of restoring flow t5 and that the 
maximal rate of adherence appears to be 1 hour after 
clamp release. ~6 Our observations in this clinical 
study corroborate these experimental findings. There 
is, however, some evidence from a meta-analysis of 
the currently available trials that the risk of postoper- 
ative thrombosis may be higher in patients whose 
arteriotomies are closed primarily (as opposed to 
routine patch angioplasty) but no evidence that 
patch type (prosthetic or vein) influences the overall 
r iskY No study has, as yet, evaluated whether pros- 
thetic or vein patches are more or less likely to embo- 
lize after surgery using TCD. 
In an attempt to prevent this devastating compli- 
cation, we decided to implement a protocol based on 
a TCD diagnosis of ongoing embolization. The hy- 
pothesis on which the project was based arose from 
observations made during our original quality con- 
trol program in 1992, in which we had observed that 
ICA thrombosis appeared to be preceded by an 
asymptomatic phase of increasing particulate micro- 
embolizadon. 3 It was predicted and subsequently 
demonstrated that a TCD diagnosis of embolization 
could thereafter be used to guide early tlaerapeutic or
surgical intervention. 6 However, logistical problems 
precluded us from implementing a program of inten- 
sive postoperative monitoring at that rime. We did, 
however, implement a policy of routine dextran ther- 
apy in all patients but abandoned this after an in- 
crease in the rate of postoperative myocardial infarc- 
tion and one death from multiorgan failure, which 
(according to the nephrologists) was directly attrib- 
utable to the administration of dextran. During this 
phase of routine postoperative dextran therapy, no 
patient had a thrombotic stroke. 
After this initial experience with a routine policy 
of postoperative dextran therapy we renewed our 
interest in serial postoperative monitoring, and fur- 
ther support for our hypothesis that thrombotic 
stroke was preceded by embolization came from Levi 
et al., 7 who showed that an embolic rate of greater 
than 50 per hour predicted stroke in 60% of patients. 
Our study has shown that only a small population of 
patients who undergo CEA (5%) have sustained 
postoperative embolization, the rate being maximal 
in the first two postoperative hours. Of most practical 
importance, ifa patient has not begun to have embo- 
lization by the end of the third postoperative hour, 
he or she is unlikely to do so thereafter. This would 
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Fig. 2. Effect of introducing an incremental-dose infu- 
sion of dextran therapy on the rate of embolization (five 
patients). Dextran was started at time 0. Rate ofemboliza- 
tion in the hour preceding starting the dextran infusion is 
also given for comparison. *In one patient, rate ofemboli- 
zation increased after starting dextran infusion, necessitat- 
ing further increase in dose. Thereafter, ate of emboliza- 
tion diminished. 
sugges t that it might be possible to stop monitoring 
after 3 hours in these patients but perhaps to con- 
tinue for longer in those who have already started to 
have embolizarion. This study has also demonstrated 
that an incremental infusion of dextran-40 rapidly 
reduced the rate of postoperative embolization, pre- 
sumably through its antiplatelet activities, and we 
assume that progression to occlusion was aborted. 
One must accept, however, that it may still be neces- 
sary to increase the dextran infusion rate in patients 
in whom the rate of embolization continues to in- 
crease, even after a period of apparent stabilization 
(patient 2; Table II). Our protocol required us to 
monitor this patient for a further 6 hours in this 
situation. Whether the latter is a rarely encountered 
phenomenon will only be answered in the future, but 
clearly has important implications with regard to the 
ability to provide technical support for this length of 
time. 
If the current hypothesis i accepted to be cor- 
rect, that is, that sustained microembolization after 
CEA is highly predictive of ICA thrombosis and 
stroke, then implementing a policy of postoperative 
TCD monitoring could have important clinical im- 
plications, not the least being the ability to staffit. At 
present we have three research staff who monitor 
patients after surgery, but that is a short-term luxury. 
If, however, patients underwent CEA on a morning 
list then access to technical staff would be undoubt- 
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edly easier than if the monitoring period extended 
well into the evening. Moreover, staffing problems 
would also be reduced by monitoring patients for 3 
hours only. Perioperative TCD monitoring (ideally) 
requires the support of a dedicated technician, but 
some surgeons and anesthetists are capable of'setting 
up the equipment hemselves. The use of a semicir- 
cular flat plate over the head to protect the probe 
from dislodgement during surgery minimizes incon- 
venience to the operating surgeon and, in fact, acts as 
a welcome hand rest to the assistants. However, 
clinicians do require some input from the TCD man- 
ufacturers, particularly with regard to the develop- 
ment of accurate and reliable automated embolus 
detection systems and the development of a head 
probe system that is more resistant o dislodgement, 
currently the commonest problem encountered ur- 
ing the early postoperative period. Alternatively, 
those centers that have the ability to monitor patients 
after surgery with TCD should consider undertaldng 
a careful appraisal of the many antiplatelet agents 
currently available to develop a safe and cost-effective 
strategy for postoperative care that does not require 
serial TCD monitoring. 
CONCLUSION 
This study has shown that a small proportion of 
patients have sustained mbolization after CEA, 
which in previous studies has been shown to be 
highly predictive of thrombotic stroke. Intervention 
with dextran reduced and subsequently stopped all 
the emboli n those in whom it was used. In conjunc- 
tiorr with a policy of intraoperative quality control 
assessment, no patient in this series of 100 CEAs had 
any perioperative neurologic omplications at all. Al- 
though implementing such a policy in the future 
could prove quite difficult, there is no doubt in our 
mind that it has significantly altered our clinical prac- 
tice. In this teaching unit, in which the majority of 
CEAs are performed by higher surgical trainees un- 
der supervision, we have (by December 1996) per- 
formed more than 380 CEAs without a patient hav- 
ing an intraoperative stroke and more than 170 
without any postoperative thromboembolic events. 
Our only recent morbidity has been intracerebral 
hemorrhage, the pathophysiologic mechanism of 
which is currently the subject of ongoing research. 
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